Retinal vein occlusion and lipoprotein (a);Occlusion veineuse retinienne et lipoproteine (a)

Journal Francais d'Ophtalmologie

Volumn 21, Issue 4, 1998, Pages 245-250

  Ribeaudeau Saindelle, F ^a,b   Glacet Bernard, A ^a,b   Lelong, F ^a,b   Coscas, G ^a,b   Soubrane, G ^a,b  

^a Centre Hospitalier Intercommunal ^*

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Hypercoagulability; Lipoprotein (a); Pathogenesis; Retinal vein occlusion

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL; LIPID; PLASMINOGEN;

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; ENDOTHELIUM CELL; FLUORESCENCE ANGIOGRAPHY; GLUCOSE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PATHOGENESIS; PROGNOSIS; RETINA VEIN OCCLUSION; TRIACYLGLYCEROL BLOOD LEVEL; VISUAL ACUITY; ADOLESCENT; ADULT; AGED; BINDING COMPETITION; BLOOD; CHEMISTRY; COMORBIDITY; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; GLAUCOMA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BINDING, COMPETITIVE; COMORBIDITY; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; GLAUCOMA; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PLASMINOGEN; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 0032036708     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. WILLIAMSON T., RUMLEY A., LOWE G.D.O. - Blood viscosity, coagulation, and activated protein C resistance in central vein occlusion: a population controlled study. Br J Ophthalmol, 1996; 80:203-208.
2. GLACET-BERNARD A., CHABANEL A., LELONG F., SAMAMA M., COSCAS G. - Elevated erythrocyte aggregation in patients with central vein occlusion and without conventional risk factors. Ophthalmology, 1994; 101:1483-1487.
3. GLACET-BERNARD A., BAYANI N., CHRETIEN P., COCHARD C., LELONG F., SAMAMA M., COSCAS G. -Antiphospholipid antibodies in retinal vascular occlusions. Arch Ophthalmol, 1994; 112:790-795.
4. GLACET-BERNARD A., COSCAS G. - Actualités sur les occlusions veineuses rétiniennes. J Fr Ophthalmol, 1993; 16:685-695.
5. WENZLER E.M., RADEMAKERS A.J.J.M., BOERS G.H.J., CRUYSBERG J., WEBERS C., DEUTMAN A. - Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol, 1993; 115:162-167.
6. BERG K.- A new serum type system in man- the LP system. Acta Pathol Microbiol Stand, 1963; 59:369-89.
7. FLEE G.M., ZUMALLEN M.E., SCANU A.M. - Isolation of apolipoprotein(a) from lipoprotein (a). J Lipid Res, 1985; 26:1224-1229.
8. EATON D.L., FLESS G.M., KOHR W.J., Mc LEAN J.W., Xu Q.T., MILLER C.G., LAWN R.M., SCANU A.M. -Partial aminoacid sequence of apolipoprotein (a) is homologous to plasminogen. Proc Nat Acad Sci USA, 1987; 84:3224-3228.
9. Mc LEAN J.W., TOMLINSON J.E., KUANG W.J., EATON D.L., CHEN E.Y., FLESS G.M., SCANU A.M., LAWN R.M. - cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature, 1987; 330:132-137.
10. ALBERS J.J., ADOLPHSON J.L., HAZZARD W.R. -Radioimmunoassay of human plasma Lp(a) lipoprotein. J Lipid Res, 1977; 18:331-338.
11. STEINMETZ J., TARALLO O., FOURNIER B., JAID M., CACES E., VOL S., TICHET J., SIEST G. - Reference values of lipoprotein (a) in a french population. Presse Med, 1994; 23:1695-1698.
12. KREMPLER F., KOSTNER G.M., BOLZANO K., SANDHOFER F. - Turnover of lipoprotein (a) in man. J Clin Invest, 1980; 65:1483-1490.
13. BERG K., DAHLEN G., FRICK M.H. - Lp(a) lipoprotein and pre-(1-lipoprotein in patients with coronary heart disease. Clin Genet, 1974; 6:230-235.
14. KOSTNER G.M., AVOGARO P., CAZZOLATO G., MARTH E., BITTOLO BON G., QUINCI G.B. - Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis, 1981; 38:51-68.
15. RHOADS G.G., DAHLEN G., BERG K., MORTON N.E., DANNENBERG A.L. - Lp(a) Lipoprotein as a risk Factor for Myocardial Infarction. JAMA, 1986; 256:2540-2544.
16. ROSENGREEN A., WILHELMSEN L., ERIKSSON E., RISBERG B., WEDEL H. - Lipoprotein (a) and coronary heart disease: a prospective case control study in a general population sample of middle age men. Br Med J, 1980; 301:1248-1251.
17. ZENKER G., KOLTRINGER P., BONE G., NIEDERKORN K., PFEIFFER K., JURGENS G. - Lipoprotein (a) as a strong indicator for cerebral disease. Stroke, 1986; 17:942-945.
18. HOFF H.F., BECK G.J., SKIBINSKI M.S., JURGENS G., O'NEILL J., KRAMER J., LYTLE B. - Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation, 1988; 77:1238-1244.
19. GLACET-BERNARD A., BLAIN P., LELONG F., SOUBRANE G., COSCAS G. - The relationship between retinal vein occlusion and lipoprotein (a). Club Gonin, Paris, 1994; no 41 (abstract).
20. BANDELLO F., D'ANGELO S. V., PARLAVECCHIA M., TAVOLA A., DELLA VALLE P., BRANCATO R., D'ANGELO A. - Hypercoagulability and high levels in patients with central vein occlusion. Thromb Haemost, 1994; 72:39-43.
21. KOSTNER G.M., VARGA M.B., ROTHENEDER M., GRUBER E., ZECHNER R. - Interaction of lipoprotein (a) with glycosaminoglycans: possible mechanism for its atherogenicity. Arteriosclerosis, 1986; 6:522a.
22. LOSCALZO J., WEINFELD M., FLESS G.M., SCANU A.M. -Lipoprotein (a), fibrin binding, and plasminogen activation. Arteriosclerosis, 1990; 10:240-245.
23. MILES L.A., FLESS G.M., LEVIN E.G., SCANU A.M., PLOW E.F. - A potential basis for the thrombotic risks associated with Lipoprotein(a). Nature, 1989; 339:301-302.
24. HAJJAR K.A., GAVISH D., BRESLOW J.L., NACHMAN R.L. - Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature, 1989; 339:303-305.
25. CARLSON L.A., HAMSTEN A., ASPLUND A. - Pronounced lowering of serum levels of Lp(a) inhyperlipidaemic subjects treated with nicotinic acid. J Int Med, 1989; 226:271-276.
26. GORDON B.R., KESLEY S.F., BILHEIMER D.W. et al. -Treatment of refractory familial hypercholesterolemia by low density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol, 1992; 70:1010-1016.